Clinical significance of lipohypertrophy without visual and palpable changes detected by ultrasonography of subcutaneous fat


Aim. To estimate clinical significance of lipohypertrophy (LH) without visual and palpable changes, detected by ultrasonography of subcutaneous fat. Materials and methods. This study included 140 diabetic patients who received insulin in basal-bolus regimen. Ultrasonography of subcutaneous fat was performed for LH diagnostics in these diabetic patients. Than clinical significance of LH without visual and palpable changes was estimated. HbA1c level, fasting and postprandial glucose, episodes of hypoglycemia, body mass index (BMI) and scheme of insulinotherapy were evaluated at the moment of LH, after 3 and 6 months in all patients. Results and discussion. After changing injection sites, good results were demonstrated by measuring glucose and HbA1c level. Thus fasting glucose decreased from 9.03±1.98 mmol/l to 7.11±0.95 mmol/l (p=0.023). Postprandial glucose reduced from 10.27±2.72 mmol/l to 9.34±1.21 mmol/l (p=0.011). HbA1c level reduced from 9.27±1.75% to 7.43±1.02% (p=0.002). Also BMI decreased from 33.75±3.49 kg/m2 to 30.5±2.96 kg/m2 (p=0.018). Conclusion. LH without visual and palpable changes could worsen compensation of glycemic control and leads to hypoglycemia and chronic Somogyi rebound. So, LH without visual and palpable is as important and clinically significant as classic LH.

Full Text

Restricted Access

About the authors

N I Volkova

Rostov State Medical University of the Ministry of Health of the Russian Federation

Rostov-on-Don, Russia

I Yu Davidenko

Rostov State Medical University of the Ministry of Health of the Russian Federation

Rostov-on-Don, Russia


  1. [Internet]. International Diabetes Federation, Diabetes Atlas, 8th ed. [Updated 2018 Jul 03; cited 2018 Jul 11]. Available from: http://www.
  2. Дедов И.И., Шестакова М.В., Майоров А.Ю., ред. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. 8-й выпуск. Москва: УП ПРИНТ; 2017.
  3. Rowe A.H, Garrison O.H. Lipodystrophy: atrophy and tumefaction of subcutaneous tissue due to insulin injections. JAMA. 1932;99:16-8. doi: 10.1001/jama.1932.02740530018005
  4. Johansson U-B, Amsberg S, Hannerz L, Wredling R, Adamson U, Arnqvist H-J. Impaired Absorption of Insulin Aspart From Lipohypertropic Injection Sites. Diabetes Care. 2005 Aug;28(8):2025-7. doi: 10.2337/diacare.28.8.2025
  5. Kordonouri O, Lauterborn R, Deiss D. Lipohypertrophy in young patients with type 1 diabetes. Diabetes Care. 2002;634(25):106-10. doi: 10.2337/diacare.25.3.634
  6. Багдасаров А.А., ред. Многотомное руководство по внутренним болезням. Том VII. Болезни эндокринной системы. Москва: Медгиз, 1966.
  7. Волкова Н.И., Давиденко И.Ю. Липогипертрофии у больных, получающих инсулинотерапию: современное состояние проблемы. Сахарный диабет. 2011;14(2):86-9.
  8. Фрид А.Х., Крейгель Дж., Грасси Дж. и др. Новые международные рекомендации по технике инъекций инсулина. Москва; 2017.
  9. Майоров А.Ю., Мельникова О.Г., Котешкова О.М. и др. Техника инъекций и инфузии при лечении сахарного диабета. Москва; 2018.
  10. Климонтов В.В., Лазарев М.М., Махотин А.А., Летягин А.Ю., Анисимова Л.А., Булумбаева Д.М., Королева Е.А., Лыков А.П. Липогипертрофии, индуцированные инсулином: клиническая и ультразвуковая характеристика. Сахарный диабет. 2018;21(4):255-63.
  11. Gentile S, Strollo F, Ceriello A, Group A-OITS. Lipodystrophy in Insulin-Treated Subjects and Other Injection-Site Skin Reactions: Are We Sure Everything is Clear? Diabetes Ther. 2016;7(3):401-9. doi: 10.1007/s13300-016-0187-6



Abstract - 41

PDF (Russian) - 6





  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Novoslobodskaya str 31c4., Moscow, 127005, Russian Federation

Managing Editor:


© 2018 "Consilium Medicum" Publishing house

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies